Two Sigma Investments’s Filana Therapeutics FLNA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$3.36M Buy
1,988,814
+1,346,413
+210% +$2.77M ﹤0.01% 2348
2025
Q4
$1.27M Buy
642,401
+77,403
+14% +$248K ﹤0.01% 2760
2025
Q3
$1.64M Buy
564,998
+38,483
+7% +$88.5K ﹤0.01% 2260
2025
Q2
$953K Buy
526,515
+93,934
+22% +$167K ﹤0.01% 2285
2025
Q1
$649K Sell
432,581
-129,501
-23% -$327K ﹤0.01% 2400
2024
Q4
$1.33M Buy
562,082
+489,936
+679% +$8.6M ﹤0.01% 1990
2024
Q3
$2.12M Buy
72,146
+53,393
+285% +$1.23M ﹤0.01% 1646
2024
Q2
$232K Buy
+18,753
New +$395K ﹤0.01% 2689
2020
Q2
Sell
-22,269
Closed -$92K 3453
2020
Q1
$92K Sell
22,269
-57,798
-72% -$383K ﹤0.01% 2858
2019
Q4
$416K Buy
+80,067
New +$138K ﹤0.01% 2938
2015
Q3
Sell
-2,920
Closed -$35K 2663
2015
Q2
$35K Buy
+2,920
New +$40K ﹤0.01% 2742
2015
Q1
Sell
-5,767
Closed -$82K 2824
2014
Q4
$82K Buy
+5,767
New +$99.8K ﹤0.01% 2145
2014
Q3
Sell
-14,453
Closed -$582K 2012
2014
Q2
$582K Buy
14,453
+6,587
+84% +$244K ﹤0.01% 1540
2014
Q1
$303K Buy
7,866
+3,652
+87% +$129K ﹤0.01% 1676
2013
Q4
$143K Buy
+4,214
New +$112K ﹤0.01% 2049

Other funds holding FLNA

Two Sigma Investments's FLNA Position: Q1 2026 in Review

Two Sigma Investments increased its Filana Therapeutics (FLNA) stake by 210% in Q1 2026, buying an estimated $2.77M and bringing the position to 1,988,814 shares worth $3.36M. The position accounts for ﹤0.01% of the portfolio, ranked #2348.

Two Sigma Investments first reported a position in FLNA in Q4 2013 and has held it in 15 quarters since. 101 funds tracked by Wall St. Rank hold FLNA as of Q1 2026.

  • Two Sigma Investments held 1,988,814 shares of Filana Therapeutics worth $3.36M as of Q1 2026.
  • Two Sigma Investments bought 1,346,413 Filana Therapeutics shares in Q1 2026, an estimated $2.77M.
  • Filana Therapeutics made up ﹤0.01% of Two Sigma Investments's portfolio in Q1 2026, its #2348 holding.
  • Two Sigma Investments first reported a position in Filana Therapeutics in Q4 2013 and has held it in 15 quarters since.
  • 101 funds tracked by Wall St. Rank held Filana Therapeutics as of Q1 2026.

Based on Two Sigma Investments's 13F filing for Q1 2026, filed 15 May 2026.